Monday, 24th October
3rd Metabolic Diseases; Breakthrough Discoveries in Diabetes & Obesity 2022
Days
Sunday, 23rd October
Monday, 24th October
Tuesday, 25th October
Wednesday, 26th October
Search
Speakers
Session 1: Insulin Resistance & Glycaemic Control
8:30AM - 10:30AM
Monday, 24th October
Chairs: Leonie Heilbronn & Brian Drew
Regulation of hepatic metabolism by MAP kinase phosphatase-1
-
Anton Bennett
Sorting out the insulin granule
-
Melkam Kebede
Tracking Insulin Resistance using Integrated Multi-Omics
-
David James
Phosphoproteomics of three exercise modalities identifies canonical signaling and C18ORF25 as an AMPK substrate regulating skeletal muscle function
-
Benjamin L Parker
Skeletal muscle NOX4 is required for adaptive responses that promote healthy ageing.
-
Dr Chrysovalantou E Xirouchaki
Morning Tea and Networking
10:30AM - 11:00AM
Monday, 24th October
Session 2: Cellular Metabolism
11:00AM - 1:00PM
Monday, 24th October
Chairs: Jacqueline Stoeckli & Adam Rose
A cooperative organelle biogenesis program regulates metabolism in mammalian cells
-
Aleksandra Filipovska
Nutrient and melanocortin activation of L cells: of mice and men
-
Damien Keating
Identification of protein mediated fatty acid transfer from lipid droplets to mitochondria
-
Matthew Watt
CRISPR – Enhanced Thermogenic Adipocytes for Cell Therapy
-
Michael Czech
Lunch Break
1:00PM - 2:00PM
Monday, 24th October
Session 3: Adipose Tissue Biology
2:00PM - 3:30PM
Monday, 24th October
Chairs: Søren Nielsen & Xiaoyong Yang
Adipogenesis and the Biogenesis of Lipid Droplets: Mechanistically Distinct Processes Connected by Phospholipids
-
Hongyuan Robert Yang
Heterogeneity and distribution of thermogenic adipocytes in humans
-
Camilla Scheele
Investigating the heterogeneity of adipocyte metabolism
-
Marin E Nelson
A nutrient-hormone axis affecting movement economy
-
Adam J Rose
Afternoon Tea
3:30PM - 4:00PM
Monday, 24th October
Plenary Session 2
4:00PM - 5:00PM
Monday, 24th October
Chair: Matthew Watt
Bioenergetics Matters to Metabolic Heath – from a view of brown fat
-
Shingo Kajimura
Poster Session 1
5:00PM - 7:00PM
Monday, 24th October
Overcoming GLP-1 Resistance in the Brain
-
Callen C Goldsmith
Central Interaction Between Histamine and Leptin
-
Natalie J Michael
AgRP neuronal activation improves outcomes in a mouse model of pancreatic cancer cachexia
-
Sarah H Lockie
Does the intestinal melanocortin-4 receptor (MC4R) play a role in regulating metabolic outcomes?
-
Rifa Haque
Targeted stimulation of brainstem NPFF neurons induces a torpor-like state and reduces glucose tolerance in mice
-
Julia Koller
Deletion of TRIM28 in the hypothalamus protects against high fat diet-induced obesity and glucose intolerance
-
Yi Wang
Sensitivity of ghrelin-induced feeding is altered in pregnancy and lactation
-
Chantelle L Murrell
Neuropeptide Y Y1-receptor signaling in the lateral habenula modulates stress-eating behaviours
-
Jemma Rezitis
The Neuronal Memory of Metabolic Adaption
-
Cait A Beddows
Insulin signaling in AgRP neurons is essential for the maintenance of metabolic health
-
Zoran Boskovic
Novel approaches to pharmacologically inhibit neurofibrosis for the treatment of metabolic disease
-
Feiyue Shi
Ceramides control the level of Coenzyme Q in mitochondria providing the basis for an Insulin Resistance Stress Pathway.
-
Alexis Diaz
Divergent whole-muscle and fibre-type-specific mitochondrial remodelling to moderate or very high-intensity exercise training.
-
David J Bishop
Harnessing genetic diversity to uncover novel muscle insulin resistance therapeutics
-
Stewart WC Masson
Dysregulation of phosphoinositide signalling confers resistance to obesity
-
KAIQIN LE
Liver adrenoceptor alpha-1b plays a key role in glucose homeostasis
-
Alexandre Caron
Functional phosphoproteomic analysis of insulin signalling in ageing bone
-
Mriga Dutt
NOX4-dependent antioxidant defence mitigates progression to NASH in obesity
-
Arthe Raajendiran
Lipidomic profiling identifies hepatic phosphatidylserine synthesis as a novel signature of resistance to non-alcoholic steatohepatitis – Targeting of phosphatidylserine synthase 1 for therapeutic intervention
-
Marziyeh Anari
INTERMITTENT FASTING INDUCES SEXUALLY DIMORPHIC HEPATIC INTERFERON ALPHA SIGNALING
-
Dylan J Harney
Protease-induced immunometabolism in mice
-
Amanda J Dodds
Hepatocyte H
2
O
2
activates T cells to promote NASH and HCC in obesity
-
Florian Wiede
Liver-derived small extracellular vesicles regulate glycemic control through increased insulin secretion and enhanced glucose effectiveness
-
Paula M Miotto
Translocation of novel long non-coding RNAs regulates adipocyte metabolism
-
Søren Nielsen
Effect of a protein kinase C epsilon inhibitor on insulin signalling in lipid-treated HepG2 hepatocytes and glucose intolerance in fat-fed mice
-
Carsten Schmitz-Peiffer
Ether lipid metabolism in obesity: insights from plasma lipidomics of large population cohort studies
-
Yvette Schooneveldt
High-dose specific omega-3 polyunsaturated fatty acid increases reperfusion in ischemic tissue: implications for use in treatment of the metabolic syndrome
-
Thi TD Dao
Plasmalogen modulation is a potential therapy for non-alcoholic fatty liver disease
-
Sudip Paul
Proteomic evaluation of hepatokine secretion in humans identifies EMILIN-1 as an inhibitor of fibrosis in non-alcoholic fatty liver disease
-
William De Nardo
Fasting blood glucose and lactate levels following high-intensity interval exercise in normoxia and hypoxia for males with normal and overweight
-
Xu Yan
Eosinophils in Adipose Tissue Thermogenesis
-
Kate Quinlan
Loss of ACAD10 does not alter whole-body metabolism or metformin action
-
Darren Henstridge
CHARACTERISING TTC39C AS A NOVEL REGULATOR OF HEPATIC LIPID METABOLISM
-
Aaron Jurrjens
To determine the role of β3-adrenergic receptors in mediating metabolic and glucose homeostasis through the melanocortin system
-
Angel Zi Shan Wee
← Sunday
Tuesday →